(Press-News.org) SEATTLE—Fatal overdoses involving prescribed opioids tripled in the United States between 1999 and 2006, climbing to almost 14,000 deaths annually—more than cocaine and heroin overdoses combined. Hospitalizations and emergency room visits related to prescription opioid pain medicines such as oxycodone (brand name Oxycontin) and hydrocodone (Vicodin) also increased dramatically in the same period.
Now a report in the August issue of Health Affairs describes a major initiative at Group Health to make opioid prescribing safer while improving care for patients with chronic pain. Health Affairs is the nation's premier health policy journal, and its August issue focuses on substance abuse.
In the Group Health initiative's first nine months, clinicians at the Seattle-based integrated health system developed and documented care plans for almost 6,000 patients—85 percent of those receiving long-term opioid therapy for chronic non-cancer pain.
Group Health's initiative was implemented well before the White House Office of Drug Control Policy, the Food and Drug Administration, and the Drug Enforcement Administration announced a national action plan in April 2011 to stem the epidemic of prescription drug abuse. Scientists from Group Health Research Institute are evaluating the initiative's effects on care, hoping Group Health's experience can help guide national efforts.
Use of prescription opioids has increased sharply since the 1980s. Excluding people with cancer and those in end-of-life care, about 4 percent of U.S. adults now use prescription opioids long term. Pharmaceutical industry advocacy and education have fueled increased opioid prescribing for chronic non-cancer pain—despite limited scientific evidence supporting the drugs' long-term effectiveness for chronic non-cancer pain.
In January 2010, Group Health Research Institute Senior Investigator Michael Von Korff, ScD, and colleagues published the first-ever study on overdose risk by dose among patients receiving prescribed opioids for chronic non-cancer pain. That study, published in the Annals of Internal Medicine, linked higher risk of fatal and nonfatal overdose to higher daily dose prescribed. His research also showed that Group Health, like other health systems nationwide, had been prescribing more opioids for chronic non-cancer pain over time—a twofold increase from 1997 to 2005.
Group Health launched a major primary care-based initiative to enhance opioid prescribing safety later in 2010. Led by Group Health Medical Director of Primary Care Claire Trescott, MD, the initiative aims to standardize use of opioids for chronic non-cancer pain, without creating undue restrictions on clinically appropriate opioid prescribing.
Using Lean management principles, Dr. Trescott worked with primary care doctors, nurses, pharmacists, pain specialists, and other clinical leaders to formulate new guidelines and related practice changes. These changes include creating standardized care plans for all patients receiving opioids long-term for chronic non-cancer pain.
"Our new opioid care plans specify one responsible prescribing physician, clarify expectations for monitoring and refills, outline treatment goals, and explain risks and side effects of long-term opioid use," said Dr. Trescott.
The individualized plans are created for each patient receiving opioids for 90 days or more. The clinician actively involves patients in the plan development and education on the risks and potential benefits of long-term opioid use. Prescription refill processes are modified to avert problems when patients seek a refill on short notice or run out of medication over a weekend. Periodic monitoring visits with their providers are scheduled, depending on dosage level and risk factors.
Recognizing the importance of provider education, Group Health's Chief of Physical Medicine and Rehabilitation Randi Beck, MD, partnered with Dr. Von Korff to develop an online clinician education course explaining the new guidelines. Funded by a Partnership for Innovation grant from the Group Health Foundation, the course aims to help primary care providers implement recommended practice changes.
By May 2011—just 9 months after the new guideline was implemented—nearly 6,000 care plans were developed with patients receiving opioids for chronic non-cancer pain (85 percent of the target population).
"We see impressive changes when our delivery system, research institute, and foundation collaborate—pooling our knowledge, skills, and resources," Dr. Von Korff said. "It's a powerful example of how a learning health care system can act quickly to address important problems in health care."
INFORMATION:
Drs. Trescott and Von Korff's co-authors are Dr. Beck and Group Health's Medical Director for Clinical Knowledge Development & Support Michelle Seelig, MD, MPH
See this website for more information about Group Health's experience with its online clinician education program:
http://www.group-health-practice-improvement-for-opioids.org
Group Health Research Institute
Founded in 1947, Group Health Cooperative is a Seattle-based, consumer-governed, nonprofit health care system. Group Health Research Institute changed its name from Group Health Center for Health Studies in 2009. Since 1983, the Institute has conducted nonproprietary public-interest research on preventing, diagnosing, and treating major health problems. Government and private research grants provide its main funding.
Health Affairs
Health Affairs, published by Project HOPE, is the leading journal of health policy. The peer-reviewed journal appears each month in print, with additional Web First papers published weekly at www.healthaffairs.org. You can also find the journal on Facebook and Twitter and download Narrative Matters on iTunes. Address inquiries to Sue Ducat at 301-841-9962 or sducat@projecthope.org
END
Wearing compression stockings may be a simple low-tech way to improve obstructive sleep apnea in patients with chronic venous insufficiency, according to French researchers.
"We found that in patients with chronic venous insufficiency, compression stockings reduced daytime fluid accumulation in the legs, which in turn reduced the amount of fluid flowing into the neck at night, thereby reducing the number of apneas and hypopnea by more than a third," said Stefania Redolfi, MD, of the University of Brescia in Italy, who led the research.
CVI occurs when a patient's veins ...
A scientist at the Gladstone Institutes has discovered a novel way to convert human skin cells into brain cells, advancing medicine and human health by offering new hope for regenerative medicine and personalized drug discovery and development.
In a paper being published online today in the scientific journal Cell Stem Cell, Sheng Ding, PhD, reveals efficient and robust methods for transforming adult skin cells into neurons that are capable of transmitting brain signals, marking one of the first documented experiments for transforming an adult human's skin cells into ...
Boston, MA (July 28, 2011) — Researchers have developed a toolkit that enables them to turn off targeted cell populations while leaving others unaffected.
Led by Susan Dymecki, a professor of genetics at Harvard Medical School, the group focused on serotonin-producing neurons, observing how mice behave in a normal environment when suddenly their serotonin neurons are turned down. While their findings affirm earlier studies, the researchers used a technique that is non-invasive and does not require anesthesia, surgeries, or knocking out a gene—each of which can cause ...
Shade & Shutter Expo and Markomm have entered into an agreement where Markomm, a SEO Denver Internet Marketing Firm, will provide PPC services to Shade & Shutter Expo. The multi layered campaign was launched July 21st in Myrtle Beach, SC and the surrounding areas. These campaigns will help Shade & Shutter Expo gain a stronger presence on the search engines, and result in more clients and sales.
Consumers today live in the information age. Technology has allowed consumers to have information at their fingertips and easily searchable through Google, Bing, Yahoo, ...
New research sheds light on why, after 300,000 years of domination, European Neanderthals abruptly disappeared. Researchers from the University of Cambridge have discovered that modern humans coming from Africa swarmed the region, arriving with over ten times the population as the Neanderthal inhabitants.
The reasons for the relatively sudden disappearance of the European Neanderthal populations across the continent around 40,000 years ago has for long remained one of the great mysteries of human evolution. After 300 millennia of living, and evidently flourishing, ...
Breast cancer screening has not played a direct part in the reductions of breast cancer mortality in recent years, says a new study published on bmj.com today.
An international team of researchers from France, the UK and Norway found that better treatment and improving health systems are more likely to have led to falling numbers of deaths from breast cancer than screening.
The number of deaths from breast cancer is falling in many developed countries, but it is difficult to determine how much of that reduction over the past 20 years of mammography screening is due ...
William D. Truax E.A. Tax Advisors, Inc. are urging those enacting a plan for estate or trust inheritance to speak with a professional tax advisor to ensure all matters of estate and trust tax are accounted for, relieving beneficiaries of the tax burden.
William D. Truax and his associates have over 30 years of experience working in the field of tax preparation. Just one of the fields his firm specializes in is estate and trust tax preparation. Effective estate and gift planning ensures the orderly transfer of assets to a client's beneficiaries. Security in these matters ...
The introduction of legislation that restricts unhealthy food, for example by reducing salt content and eliminating industrial trans fats, would prevent thousands of cases of heart disease in England and Wales and save the NHS millions of pounds, finds research published on bmj.com today.
Heart disease and stroke cause over 150,000 deaths every year in the UK and yet over 80% of premature heart disease is avoidable, say the authors.
They add that established research has already indicated that individuals who consume too much salt and eat food which is high in industrial ...
Permeon Biologics, a biopharmaceutical company pioneering a novel class of intracellular protein biologics, today announced the discovery of an entirely new class of naturally occurring human supercharged proteins called Intraphilins™. The sequence and structure of these naturally supercharged human proteins enable biologic drugs to penetrate and function inside of mammalian cells. This new class of proteins is the foundation of Permeon Biologics' novel Intraphilin™ Technology Platform and provides an innovative approach to develop intracellular protein biologic drugs, ...
Boston, MA – Global population is expected to hit 7 billion later this year, up from 6 billion in 1999. Between now and 2050, an estimated 2.3 billion more people will be added—nearly as many as inhabited the planet as recently as 1950. New estimates from the Population Division of the Department of Economic and Social Affairs of the United Nations also project that the population will reach 10.1 billion in 2100.
These sizable increases represent an unprecedented global demographic upheaval, according to David Bloom, Clarence James Gamble Professor of Economics and ...
